Qingdao Vland Biotech INC. (SHA:603739)
China
· Delayed Price · Currency is CNY 14.98
+0.26 (1.77%)
Apr 29, 2026, 3:00 PM CST
SHA:603739 Revenue
In the year 2025, Qingdao Vland Biotech INC. had annual revenue of 1.37B CNY with 3.43% growth. Qingdao Vland Biotech INC. had revenue of 350.33M in the quarter ending December 31, 2025, a decrease of -6.61%.
Revenue
1.37B
Revenue Growth
+3.43%
P/S Ratio
2.77
Revenue / Employee
889.98K
Employees
1,535
Market Cap
3.79B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 1.37B | 45.36M | 3.43% |
| Dec 31, 2024 | 1.32B | 121.86M | 10.16% |
| Dec 31, 2023 | 1.20B | 35.74M | 3.07% |
| Dec 31, 2022 | 1.16B | 12.34M | 1.07% |
| Dec 31, 2021 | 1.15B | 190.57M | 19.85% |
| Dec 31, 2020 | Pro | Pro | Pro |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Guanhao Biotech | 387.75M |
| Shanghai Serum Bio-Technology | 197.68M |
| Baolingbao Biology | 2.81B |
| Zhejiang Wecome Pharmaceutical Company | 131.67M |
| Zhejiang Shouxiangu Pharmaceutical | 642.66M |
| Hinova Pharmaceuticals | 46.50M |
| Boji Medical Technology | 949.94M |
| Shanghai Shen Lian Biomedical | 288.27M |